311 related articles for article (PubMed ID: 2328864)
1. [Evaluation of the effects of vasodilator therapy in primary pulmonary hypertension. Experience in 7 cases].
Lanzarini L; Gavazzi A; Mussini A; Graziano G; Campana C; Bargiggia G; Angoli L; Aimè E; Arbustini E; Montemartini C
G Ital Cardiol; 1990 Feb; 20(2):114-22. PubMed ID: 2328864
[TBL] [Abstract][Full Text] [Related]
2. [10 years' experience in the use of vasodilator agents in the treatment of primary pulmonary arterial hypertension (P-PAH) (1977-1987)].
Beltrán Gámez ME; Sandoval Zarate J; Seoane M; Lupi-Herrera E
Arch Inst Cardiol Mex; 1988; 58(4):281-91. PubMed ID: 3190363
[TBL] [Abstract][Full Text] [Related]
3. Acute improved hemodynamics following inhaled iloprost in chronic thromboembolic pulmonary hypertension.
Krug S; Hammerschmidt S; Pankau H; Wirtz H; Seyfarth HJ
Respiration; 2008; 76(2):154-9. PubMed ID: 17804899
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and hemodynamic evaluation of 6-week treatment of pulmonary hypertension in chronic obstructive lung diseases (COLD) with low dose of prazosin].
Lewczuk J; Spikowski J; Sobkowicz-Woźniak B; Porada A; Wrabec K; Trzesicka M; Piszko P; Palka PS; Szczygielski J
Kardiol Pol; 1990; 33(6):358-64. PubMed ID: 2084301
[TBL] [Abstract][Full Text] [Related]
5. [Therapy of primary pulmonary arterial hypertension: current status].
Solèr M
Schweiz Med Wochenschr; 1994 Oct; 124(39):1701-7. PubMed ID: 7939536
[TBL] [Abstract][Full Text] [Related]
6. [Clinical interpretation for the pressure-flow relationships in extrinsic allergic alveolitis and in interstitial lung disease pulmonary hypertension patients. Should we care for the lung, the pulmonary artery pressure or both?].
Lupi-Herrera E; Santos-Martínez LE; Pulido T; Sandoval J
Arch Cardiol Mex; 2009; 79(2):91-103. PubMed ID: 19722378
[TBL] [Abstract][Full Text] [Related]
7. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
[TBL] [Abstract][Full Text] [Related]
8. Acute hemodynamic effects of nicorandil in patients with primary pulmonary arterial hypertension.
Yadav R; Anandaraja S; Bhargava B; Jindal R; Goswami KC
Indian Heart J; 2005; 57(6):666-9. PubMed ID: 16521635
[TBL] [Abstract][Full Text] [Related]
9. Sildenafil for primary and secondary pulmonary hypertension.
Watanabe H; Ohashi K; Takeuchi K; Yamashita K; Yokoyama T; Tran QK; Satoh H; Terada H; Ohashi H; Hayashi H
Clin Pharmacol Ther; 2002 May; 71(5):398-402. PubMed ID: 12011826
[TBL] [Abstract][Full Text] [Related]
10. Comparison between two drugs on the hemodynamic evaluation of pulmonary hypertension prior to heart transplantation.
Mogollón Jiménez MV; Escoresca Ortega AM; Hinojosa Pérez R; Lage Gallé E; Herruzo Avilés A; Sobrino Márquez M; Frutos López M; Romero Rodríguez N; Pérez de la Yglesia R; Martínez Martínez A
Transplant Proc; 2008 Nov; 40(9):3009-11. PubMed ID: 19010174
[TBL] [Abstract][Full Text] [Related]
11. [Variable hemodynamic response to nifedipine in pulmonary hypertension secondary to chronic obstructive bronchopathy and pulmonary fibrosis].
Domenighetti G
Schweiz Med Wochenschr; 1985 Sep; 115(39):1345-7. PubMed ID: 4071009
[TBL] [Abstract][Full Text] [Related]
12. Haemodynamic correlation with lung biopsy findings in isolated ventricular septal defect with or without pulmonary hypertension.
Zakaria M
Hokkaido Igaku Zasshi; 1997 Nov; 72(6):607-19. PubMed ID: 9465314
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of nifedipine in pulmonary hypertension.
Klugmann S; Salvi A; Fioretti P; Camerini F
G Ital Cardiol; 1982; 12(7):505-8. PubMed ID: 7169146
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
[TBL] [Abstract][Full Text] [Related]
15. The response to inhaled nitric oxide in patients with pulmonary artery hypertension is not masked by baseline vasodilator use.
Krasuski RA; Wang A; Harrison JK; Tapson VF; Bashore TM
Am Heart J; 2005 Oct; 150(4):725-8. PubMed ID: 16209974
[TBL] [Abstract][Full Text] [Related]
16. [Inhalation of a prostacyclin analog (iloprost) in primary and secondary pulmonary hypertension].
Andreassen AK; Madsen S; Kjekshus J; Simonsen S
Tidsskr Nor Laegeforen; 2001 Apr; 121(10):1220-3. PubMed ID: 11402748
[TBL] [Abstract][Full Text] [Related]
17. Primary pulmonary hypertension. An analysis of 28 cases and a review of the literature.
Hughes JD; Rubin LJ
Medicine (Baltimore); 1986 Jan; 65(1):56-72. PubMed ID: 2867454
[TBL] [Abstract][Full Text] [Related]
18. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
[TBL] [Abstract][Full Text] [Related]
19. Unpredictable response to vasodilator therapy in primary pulmonary hypertension.
Schmiedt MI; Shettigar UR; Siddique M; Barbier G; Bialow M; Carranza S
Int J Clin Pharmacol Ther; 1998 Aug; 36(8):435-40. PubMed ID: 9726697
[TBL] [Abstract][Full Text] [Related]
20. Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil.
Adnot S; Samoyeau R; Weitzenblum E
Blood Press Suppl; 1995; 3():47-57. PubMed ID: 8535542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
